Download as PDF

Proceedings of the Standing Senate Committee on
Social Affairs, Science and Technology

First Session, Forty-first Parliament, 2011-12

Chair: The Honourable KELVIN KENNETH OGILVIE


Wednesday, October 24, 2012
Thursday, October 25, 2012

Issue No. 23

Seventeenth and eighteenth meetings on:

Study on prescription pharmaceuticals in Canada


WITNESSES

Wednesday, October 24, 2012

National Association of Pharmacy Regulatory Authorities:

Carole Bouchard, Executive Director.

Canadian Medical Association:

Dr. Anna Reid, President;

Millicent Toombs, Director, Public Health Department.

Canadian Nurses Association:

Barbara Mildon, President.

Thursday, October 25, 2012

Rx&D:

Ken Hughes, Vice-President, Scientific and Regulatory Affairs;

Stan Glezer, Vice-President, Evidence, Value and Access, Sanofi.

Canadian Generic Pharmaceutical Association:

Dr. Colin D'Cunha, Director, Global Medical Affairs, Apotex Inc.

BIOTECanada:

Andrew Casey, President and Chief Executive Officer;

Loretta Del Bosco, President and Chief Executive Officer, Regulatory Affairs, Abbott Canada Ltd.


MEMBERS OF THE COMMITTEE

The Honourable Kelvin Kenneth Ogilvie, Chair

The Honourable Art Eggleton, P.C., Deputy Chair

and

The Honourable Senators:

*Cowan (or Tardif), Enverga, *LeBreton, P.C. (or Carignan), Martin, Mercer, Merchant, Moore, Munson, Raine, Seidman, Seth, Verner, P.C.

* Ex officio members

(Quorum 4)

Changes in membership of the committee:

Pursuant to rule 12-5, membership of the committee was amended as follows:

The Honourable Senator Mercer replaced the Honourable Senator Cordy (October 25, 2012).

The Honourable Senator Moore replaced the Honourable Senator Dyck (October 25, 2012).

The Honourable Senator Raine replaced the Honourable Senator Eaton (October 23, 2012).

The Honourable Senator Eaton replaced the Honourable Senator Buth (October 19, 2012).

The Honourable Senator Martin replaced the Honourable Senator Unger (October 19, 2012).